| Primary |
| Drug Use For Unknown Indication |
20.5% |
| Anxiety Disorder |
10.3% |
| Reflux Oesophagitis |
10.3% |
| Restlessness |
10.3% |
| Myocardial Ischaemia |
7.7% |
| Ventricular Tachycardia |
7.7% |
| Arrhythmia |
5.1% |
| Tachycardia |
5.1% |
| Ventricular Arrhythmia |
5.1% |
| Angina Pectoris |
2.6% |
| Atrial Fibrillation |
2.6% |
| Atrial Flutter |
2.6% |
| Cardiac Failure Chronic |
2.6% |
| Constipation |
2.6% |
| Depression |
2.6% |
| Product Used For Unknown Indication |
2.6% |
|
| Erythema |
15.4% |
| Pulmonary Oedema |
15.4% |
| Vomiting |
15.4% |
| Cardiac Arrest |
7.7% |
| Drug Eruption |
7.7% |
| Drug Level Increased |
7.7% |
| Oculomucocutaneous Syndrome |
7.7% |
| Stomach Discomfort |
7.7% |
| Ventricular Hypokinesia |
7.7% |
| Ventricular Tachycardia |
7.7% |
|
| Secondary |
| Drug Use For Unknown Indication |
18.4% |
| Hypertension |
15.1% |
| Atrial Fibrillation |
8.7% |
| Schizophrenia |
6.6% |
| Arrhythmia |
5.8% |
| Acute Myocardial Infarction |
5.2% |
| Emphysema |
5.0% |
| Cardiac Failure |
4.8% |
| Depression |
3.9% |
| Mineral Supplementation |
3.5% |
| Diabetes Mellitus |
3.1% |
| Product Used For Unknown Indication |
2.9% |
| Insomnia |
2.7% |
| Tachycardia |
2.7% |
| Cancer Pain |
2.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.5% |
| Blood Pressure Management |
1.9% |
| Basedow's Disease |
1.7% |
| Endotracheal Intubation |
1.7% |
| Infection Prophylaxis |
1.7% |
|
| Urinary Retention |
14.3% |
| Toxic Epidermal Necrolysis |
10.0% |
| Tonic Convulsion |
8.6% |
| Shock |
7.1% |
| Multi-organ Failure |
5.7% |
| Oculomucocutaneous Syndrome |
5.7% |
| Respiratory Arrest |
5.7% |
| Gastroenteritis |
4.3% |
| Hyperkalaemia |
4.3% |
| Liver Disorder |
4.3% |
| Neuroleptic Malignant Syndrome |
4.3% |
| Drug Eruption |
2.9% |
| Embolic Stroke |
2.9% |
| Malaise |
2.9% |
| Pancytopenia |
2.9% |
| Platelet Count Decreased |
2.9% |
| Pulmonary Venous Thrombosis |
2.9% |
| Skin Exfoliation |
2.9% |
| Supraventricular Tachycardia |
2.9% |
| Tremor |
2.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
16.4% |
| Hypertension |
13.1% |
| Atrial Fibrillation |
12.8% |
| Product Used For Unknown Indication |
10.7% |
| Cardiac Failure |
7.1% |
| Prophylaxis |
5.0% |
| Pain |
4.0% |
| Rheumatoid Arthritis |
3.9% |
| Diabetes Mellitus |
3.4% |
| Insomnia |
3.3% |
| Angina Pectoris |
3.1% |
| Constipation |
2.4% |
| Gastritis |
2.4% |
| Pneumonia |
2.2% |
| Asthma |
1.9% |
| Mineral Supplementation |
1.9% |
| Arrhythmia |
1.8% |
| Gastric Ulcer |
1.6% |
| Interstitial Lung Disease |
1.6% |
| Colon Cancer |
1.5% |
|
| White Blood Cell Count Decreased |
7.9% |
| Cardiac Failure |
7.4% |
| Vomiting |
7.4% |
| Multi-organ Failure |
6.5% |
| Pyrexia |
6.5% |
| Pneumonia |
6.0% |
| Platelet Count Decreased |
5.6% |
| Hepatic Function Abnormal |
5.1% |
| Tachycardia |
5.1% |
| Interstitial Lung Disease |
4.7% |
| Thrombocytopenia |
4.7% |
| Cerebral Infarction |
4.2% |
| Sepsis |
4.2% |
| Ventricular Fibrillation |
4.2% |
| Malaise |
3.7% |
| Somnolence |
3.7% |
| Ventricular Tachycardia |
3.7% |
| Death |
3.3% |
| White Blood Cell Count Increased |
3.3% |
| Hemiplegia |
2.8% |
|
| Interacting |
| Chronic Myeloid Leukaemia |
31.0% |
| Product Used For Unknown Indication |
31.0% |
| Atrial Fibrillation |
13.8% |
| Arrhythmia |
6.9% |
| Hypertrophic Cardiomyopathy |
6.9% |
| Ventricular Fibrillation |
6.9% |
| Onychomycosis |
3.4% |
|
| Electrocardiogram Qt Prolonged |
33.3% |
| Hypotension |
16.7% |
| Medication Error |
16.7% |
| Shock |
16.7% |
| Ventricular Extrasystoles |
16.7% |
|
